Thomas Gilliland

978 total citations
13 papers, 452 citations indexed

About

Thomas Gilliland is a scholar working on Surgery, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Thomas Gilliland has authored 13 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 4 papers in Epidemiology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Thomas Gilliland's work include Lipoproteins and Cardiovascular Health (5 papers), Liver Disease and Transplantation (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Thomas Gilliland is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Liver Disease and Transplantation (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Thomas Gilliland collaborates with scholars based in United States, Canada and Italy. Thomas Gilliland's co-authors include Justin Cotney, Lei Song, Gerald S. Shadel, Sharen E. McKay, Nuno Raimundo, Joseph Santos‐Sacchi, Timothy E. Shutt, Min‐Xin Guan, Spencer N. Church and Mark W. Maxfield and has published in prestigious journals such as Cell, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Thomas Gilliland

12 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Gilliland United States 8 198 159 72 70 65 13 452
Koki Abe Japan 12 210 1.1× 180 1.1× 71 1.0× 96 1.4× 75 1.2× 29 500
Michael S. Sabbah United States 8 156 0.8× 117 0.7× 156 2.2× 26 0.4× 75 1.2× 17 429
Zoë E. Clayton Australia 13 114 0.6× 201 1.3× 53 0.7× 72 1.0× 66 1.0× 21 568
Jinggang Xia China 14 141 0.7× 95 0.6× 143 2.0× 35 0.5× 21 0.3× 39 404
Juesheng Yang China 8 107 0.5× 225 1.4× 104 1.4× 36 0.5× 51 0.8× 19 417
Nianguo Dong China 13 109 0.6× 141 0.9× 196 2.7× 73 1.0× 43 0.7× 38 468
Ulrich Becher Germany 10 62 0.3× 184 1.2× 95 1.3× 27 0.4× 32 0.5× 24 400
Basile Gravez France 12 84 0.4× 153 1.0× 62 0.9× 28 0.4× 35 0.5× 13 404
Jiana Huang China 11 78 0.4× 325 2.0× 55 0.8× 98 1.4× 21 0.3× 33 578
С. М. Минасян Russia 11 96 0.5× 147 0.9× 66 0.9× 30 0.4× 22 0.3× 40 397

Countries citing papers authored by Thomas Gilliland

Since Specialization
Citations

This map shows the geographic impact of Thomas Gilliland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gilliland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gilliland more than expected).

Fields of papers citing papers by Thomas Gilliland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gilliland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gilliland. The network helps show where Thomas Gilliland may publish in the future.

Co-authorship network of co-authors of Thomas Gilliland

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Gilliland. A scholar is included among the top collaborators of Thomas Gilliland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Gilliland. Thomas Gilliland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lee, Jiwoo, Thomas Gilliland, Jacqueline S. Dron, et al.. (2024). Integrative Metabolomics Differentiate Coronary Artery Disease, Peripheral Artery Disease, and Venous Thromboembolism Risks. Arteriosclerosis Thrombosis and Vascular Biology. 44(9). 2108–2117. 4 indexed citations
2.
Bellomo, Tiffany R., Yuxi Liu, Thomas Gilliland, et al.. (2024). Associations between lipoprotein(a), oxidized phospholipids, and extracoronary vascular disease. Journal of Lipid Research. 65(7). 100585–100585. 6 indexed citations
3.
Gilliland, Thomas, Jacqueline S. Dron, Margaret Sunitha Selvaraj, et al.. (2024). Genetic Architecture and Clinical Outcomes of Combined Lipid Disturbances. Circulation Research. 135(2). 265–276. 4 indexed citations
4.
Gilliland, Thomas, Yuxi Liu, Reza Mohebi, et al.. (2023). Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes. Journal of the American College of Cardiology. 81(18). 1780–1792. 50 indexed citations
5.
Trinder, Mark, Kaavya Paruchuri, Sara Haidermota, et al.. (2022). Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk. Journal of the American College of Cardiology. 79(7). 617–628. 59 indexed citations
6.
Sánchez, Pablo J., et al.. (2019). CONTRIBUTORS TO RESPIRATORY FAILURE AND OUTCOMES IN THE CARDIAC INTENSIVE CARE UNIT. Journal of the American College of Cardiology. 73(9). 216–216.
7.
Bohula, Erin A., et al.. (2018). Editor’s Choice-Prospective registry of cardiac critical illness in a modern tertiary care Cardiac Intensive Care Unit. European Heart Journal Acute Cardiovascular Care. 8(8). 755–761. 26 indexed citations
8.
Gilliland, Thomas, Sylvie Dufour, Gerald I. Shulman, Kitt Falk Petersen, & Sukru Emre. (2016). Resolution of non‐alcoholic steatohepatitis after growth hormone replacement in a pediatric liver transplant patient with panhypopituitarism. Pediatric Transplantation. 20(8). 1157–1163. 18 indexed citations
9.
Sallam, Tamer, Ayaka Ito, Xin Rong, et al.. (2014). The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis. Journal of Lipid Research. 55(6). 1120–1130. 23 indexed citations
10.
Fortune, Brett E., et al.. (2013). Liver Transplantation for Hepatocellular Carcinoma. Journal of Clinical Gastroenterology. 47(Supplement 1). S37–S42. 22 indexed citations
11.
Raimundo, Nuno, Lei Song, Timothy E. Shutt, et al.. (2012). Mitochondrial Stress Engages E2F1 Apoptotic Signaling to Cause Deafness. Cell. 148(4). 716–726. 157 indexed citations
12.
Patterson, Joseph T., Thomas Gilliland, Mark W. Maxfield, et al.. (2012). Tissue-Engineered Vascular Grafts for Use in the Treatment of Congenital Heart Disease: From the Bench to the Clinic and Back Again. Regenerative Medicine. 7(3). 409–419. 82 indexed citations
13.
Gilliland, Thomas. (2004). The dramatic mirror. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koki Abe Breakdown of academic impact, for papers by Michael S. Sabbah Breakdown of academic impact, for papers by Zoë E. Clayton Breakdown of academic impact, for papers by Jinggang Xia Breakdown of academic impact, for papers by Juesheng Yang Breakdown of academic impact, for papers by Nianguo Dong Breakdown of academic impact, for papers by Ulrich Becher Breakdown of academic impact, for papers by Basile Gravez Breakdown of academic impact, for papers by Jiana Huang Breakdown of academic impact, for papers by С. М. Минасян
Rankless by CCL
2026